What Happens When Smoking Psilocybin Mushrooms?

Psilocybin is a naturally occurring psychedelic compound found in over 200 species of mushrooms, often referred to as “magic mushrooms.” These fungi are commonly consumed orally to induce altered perceptions and experiences. Psilocybin itself is a prodrug, meaning it is biologically inactive until converted within the body.

Why Smoking Psilocybin is Ineffective

Psilocybin is a tryptamine alkaloid. It is relatively sensitive to high temperatures, particularly those involved in combustion. When mushrooms containing psilocybin are subjected to the intense heat of smoking, the psilocybin molecule rapidly degrades. This degradation significantly reduces or eliminates its psychoactive properties before it can be inhaled and absorbed into the bloodstream.

In contrast, when psilocybin is consumed orally, it undergoes a crucial transformation in the body. Upon ingestion, enzymes dephosphorylate psilocybin into psilocin. Psilocin is the active compound responsible for the psychedelic effects, as it mimics serotonin and binds to serotonin receptors in the brain. This metabolic conversion process is largely bypassed or rendered inefficient when psilocybin is smoked, making it an ineffective method for experiencing its intended effects.

Potential Health Concerns of Smoking Psilocybin

Inhaling smoke from any organic material introduces harmful toxins and particulate matter into the respiratory system. This can lead to irritation of the lungs and airways, causing long-term damage. It also increases the risk of various respiratory issues and may contribute to lung cancer over time.

Beyond general smoke inhalation, smoking mushroom material carries specific risks. Mushrooms can harbor mold spores, bacteria, and other contaminants. Inhaling these substances directly into the lungs can lead to inflammation and infections. Misidentifying mushroom species is also a danger; smoking a toxic variety could result in severe illness, organ failure, or even death.

Legal Considerations

Psilocybin is classified as a Schedule I controlled substance under federal law. This classification indicates a high potential for abuse and no currently accepted medical use in treatment. Consequently, possession, cultivation, and distribution are illegal federally and can lead to substantial fines and lengthy prison sentences.

While federal law remains strict, there has been a movement towards decriminalization at state and local levels. Cities such as Denver, Oakland, Santa Cruz, Washington D.C., and Seattle have decriminalized psilocybin, making its possession or use a low law enforcement priority. Oregon and Colorado have gone further, decriminalizing psilocybin for personal possession and establishing frameworks for supervised therapeutic use in licensed facilities. Decriminalization does not equate to full legalization and still carries potential legal consequences.

Botulism: Understanding, Preventing, and Treating the Threat

Tagrisso’s Role in Treating EGFR Exon 20 Mutations

What Are Negative Inotropes and Why Are They Used?